Small Cell Lung Cancer (SCLC) Therapeutics - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Small Cell Lung Cancer (SCLC) Therapeutics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Small Cell Lung Cancer (SCLC) Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Small Cell Lung Cancer (SCLC) Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Cancer Therapy Centers grew percent.
This report studies and analyses global Small Cell Lung Cancer (SCLC) Therapeutics status and future trends, to help determine the Small Cell Lung Cancer (SCLC) Therapeutics market size of the total market opportunity by Therapy Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Small Cell Lung Cancer (SCLC) Therapeutics, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Small Cell Lung Cancer (SCLC) Therapeutics market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Small Cell Lung Cancer (SCLC) Therapeutics by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Small Cell Lung Cancer (SCLC) Therapeutics by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Small Cell Lung Cancer (SCLC) Therapeutics key consuming regions, consumption value and demand structure
(5) Small Cell Lung Cancer (SCLC) Therapeutics industry chains, upstream, midstream and downstream
Understanding Market Segments by Key Players: Insights and Opportunities
ZIOPHARM Oncology
GlaxoSmithKline
Menarini
Bristol-Myers Squibb
Sanofi
Novartis AG
Elekta AB
Siemens Healthcare GmbH
G1 Therapeutics
Market segment by Therapy Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Others
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Hospitals
Cancer Therapy Centers
Others (Specialty Clinics)
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Uncovering Market Potential: What Our Report Includes
Chapter 1: to describe Small Cell Lung Cancer (SCLC) Therapeutics product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Small Cell Lung Cancer (SCLC) Therapeutics market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Small Cell Lung Cancer (SCLC) Therapeutics market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Small Cell Lung Cancer (SCLC) Therapeutics industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Therapy Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Small Cell Lung Cancer (SCLC) Therapeutics Definition
1.2 Global Small Cell Lung Cancer (SCLC) Therapeutics Market Size and Forecast
1.3 China Small Cell Lung Cancer (SCLC) Therapeutics Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Small Cell Lung Cancer (SCLC) Therapeutics Market Size: China VS Global Growth Rate, 2018-2029
1.6 Small Cell Lung Cancer (SCLC) Therapeutics Market Dynamics
1.6.1 Small Cell Lung Cancer (SCLC) Therapeutics Market Drivers
1.6.2 Small Cell Lung Cancer (SCLC) Therapeutics Market Restraints
1.6.3 Small Cell Lung Cancer (SCLC) Therapeutics Industry Trends
1.6.4 Small Cell Lung Cancer (SCLC) Therapeutics Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Small Cell Lung Cancer (SCLC) Therapeutics, Global Market Share by Company, 2018-2023
2.2 Global Small Cell Lung Cancer (SCLC) Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Small Cell Lung Cancer (SCLC) Therapeutics Concentration Ratio
2.4 Global Small Cell Lung Cancer (SCLC) Therapeutics Mergers & Acquisitions, Expansion Plans
2.5 Global Small Cell Lung Cancer (SCLC) Therapeutics Major Companies Product Type
2.6 Head Office and Small Cell Lung Cancer (SCLC) Therapeutics Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Small Cell Lung Cancer (SCLC) Therapeutics, China Market Share by Company, 2018-2023
3.2 China Small Cell Lung Cancer (SCLC) Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Small Cell Lung Cancer (SCLC) Therapeutics Industry Chain
4.2 Small Cell Lung Cancer (SCLC) Therapeutics Upstream Analysis
4.2.1 Small Cell Lung Cancer (SCLC) Therapeutics Core Raw Materials
4.2.2 Main Manufacturers of Small Cell Lung Cancer (SCLC) Therapeutics Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Small Cell Lung Cancer (SCLC) Therapeutics Production Mode
4.6 Small Cell Lung Cancer (SCLC) Therapeutics Procurement Model
4.7 Small Cell Lung Cancer (SCLC) Therapeutics Industry Sales Model and Sales Channels
4.7.1 Small Cell Lung Cancer (SCLC) Therapeutics Sales Model
4.7.2 Small Cell Lung Cancer (SCLC) Therapeutics Typical Distributors
5 Sights by Therapy Type
5.1 Small Cell Lung Cancer (SCLC) Therapeutics Classification
5.1.1 Chemotherapy
5.1.2 Targeted Therapy
5.1.3 Immunotherapy
5.1.4 Others
5.2 By Therapy Type, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Therapy Type, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value, 2018-2029
6 Sights by Application
6.1 Small Cell Lung Cancer (SCLC) Therapeutics Segment by Application
6.1.1 Hospitals
6.1.2 Cancer Therapy Centers
6.1.3 Others (Specialty Clinics)
6.2 By Application, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Small Cell Lung Cancer (SCLC) Therapeutics & Forecasts, 2018-2029
7.3.2 By Country, North America Small Cell Lung Cancer (SCLC) Therapeutics Market Size Market Share
7.4 Europe
7.4.1 Europe Small Cell Lung Cancer (SCLC) Therapeutics Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Small Cell Lung Cancer (SCLC) Therapeutics Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Small Cell Lung Cancer (SCLC) Therapeutics Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Small Cell Lung Cancer (SCLC) Therapeutics Market Size Market Share
7.6 South America
7.6.1 South America Small Cell Lung Cancer (SCLC) Therapeutics Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Small Cell Lung Cancer (SCLC) Therapeutics Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Small Cell Lung Cancer (SCLC) Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.3.2 By Therapy Type, U.S. Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.4.2 By Therapy Type, Europe Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.5.2 By Therapy Type, China Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.6.2 By Therapy Type, Japan Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.7.2 By Therapy Type, South Korea Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.8.2 By Therapy Type, Southeast Asia Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.9.2 By Therapy Type, India Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Small Cell Lung Cancer (SCLC) Therapeutics Market Size, 2018-2029
8.10.2 By Therapy Type, Middle East & Africa Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Small Cell Lung Cancer (SCLC) Therapeutics Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 ZIOPHARM Oncology
9.1.1 ZIOPHARM Oncology Company Information, Head Office, Market Area and Industry Position
9.1.2 ZIOPHARM Oncology Company Profile and Main Business
9.1.3 ZIOPHARM Oncology Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.1.4 ZIOPHARM Oncology Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.1.5 ZIOPHARM Oncology Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.2.2 GlaxoSmithKline Company Profile and Main Business
9.2.3 GlaxoSmithKline Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.2.4 GlaxoSmithKline Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.2.5 GlaxoSmithKline Recent Developments
9.3 Menarini
9.3.1 Menarini Company Information, Head Office, Market Area and Industry Position
9.3.2 Menarini Company Profile and Main Business
9.3.3 Menarini Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.3.4 Menarini Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.3.5 Menarini Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Company Information, Head Office, Market Area and Industry Position
9.4.2 Bristol-Myers Squibb Company Profile and Main Business
9.4.3 Bristol-Myers Squibb Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.4.4 Bristol-Myers Squibb Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Sanofi
9.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.5.2 Sanofi Company Profile and Main Business
9.5.3 Sanofi Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.5.4 Sanofi Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.5.5 Sanofi Recent Developments
9.6 Novartis AG
9.6.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
9.6.2 Novartis AG Company Profile and Main Business
9.6.3 Novartis AG Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.6.4 Novartis AG Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.6.5 Novartis AG Recent Developments
9.7 Elekta AB
9.7.1 Elekta AB Company Information, Head Office, Market Area and Industry Position
9.7.2 Elekta AB Company Profile and Main Business
9.7.3 Elekta AB Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.7.4 Elekta AB Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.7.5 Elekta AB Recent Developments
9.8 Siemens Healthcare GmbH
9.8.1 Siemens Healthcare GmbH Company Information, Head Office, Market Area and Industry Position
9.8.2 Siemens Healthcare GmbH Company Profile and Main Business
9.8.3 Siemens Healthcare GmbH Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.8.4 Siemens Healthcare GmbH Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.8.5 Siemens Healthcare GmbH Recent Developments
9.9 G1 Therapeutics
9.9.1 G1 Therapeutics Company Information, Head Office, Market Area and Industry Position
9.9.2 G1 Therapeutics Company Profile and Main Business
9.9.3 G1 Therapeutics Small Cell Lung Cancer (SCLC) Therapeutics Models, Specifications and Application
9.9.4 G1 Therapeutics Small Cell Lung Cancer (SCLC) Therapeutics Revenue and Gross Margin, 2018-2023
9.9.5 G1 Therapeutics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Small Cell Lung Cancer (SCLC) Therapeutics Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|